Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Recent advances in the hepatitides

A G Ramos-Soriano¹, K B Schwarz

¹Division of Pediatric Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, Baltimore, Maryland.

Gastroenterology Clinics of North America

|December 1, 1994

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Quality of life in adolescents with hepatitis C treated with sofosbuvir and ribavirin.

Journal of viral hepatitis·2017

Same author

Implementation of feeding guidelines in infants at risk of intestinal failure.

Journal of perinatology : official journal of the California Perinatal Association·2015

Same author

Variability of hepatitis E serologic assays in a pediatric liver transplant recipient: challenges to diagnosing hepatitis E virus infection in the United States.

Transplant infectious disease : an official journal of the Transplantation Society·2015

Same author

Longitudinal changes in liver fibrosis in children with sickle cell disease undergoing chronic transfusion therapy.

Acta gastro-enterologica Belgica·2013

Same author

Living donor liver transplantation in children: a single North American center experience over two decades.

Pediatric transplantation·2012

Same author

Chronic diarrhea, ascites, and protein-losing enteropathy in an infant with hepatic venous outflow obstruction after liver transplantation.

Pediatric transplantation·2012

Same journal

Living Donor Intestinal and Liver Transplantation.

Gastroenterology clinics of North America·2026

Same journal

Living Abdominal Organ Donation: A Plan B That Saves Lives.

Gastroenterology clinics of North America·2026

Same journal

Long-Term Outcomes of Living Liver Donors.

Gastroenterology clinics of North America·2026

Same journal

Perioperative Management of Living Liver Donor Patients.

Gastroenterology clinics of North America·2026

Same journal

Living Donor Liver Transplantation for Colorectal Cancer Liver Metastasis.

Gastroenterology clinics of North America·2026

Same journal

Living Donor Liver Graft in Adult Populations: Donor Selection and Workup.

Gastroenterology clinics of North America·2026

See all related articles

Advances in understanding viral hepatitis include new agents (delta, C, E), universal hepatitis B virus (HBV) immunization, and interferon treatments for chronic hepatitis B and C. Further research is needed for other viral types.

Area of Science:

Hepatology
Virology
Immunology

Background:

Five major types of viral hepatitis are known.
Recent discoveries include hepatitis delta, C, and E viruses.
Hepatitis B virus (HBV) infection has significant public health implications.

Purpose of the Study:

To review the clinical spectra of viral hepatitis.
To highlight advancements in hepatitis B prevention and treatment.
To identify future research directions for viral hepatitis management.

Main Methods:

Literature review of recent studies on viral hepatitis.
Analysis of clinical data related to hepatitis agents.
Evaluation of treatment efficacy for chronic hepatitis.

Related Experiment Videos

Main Results:

The detection of hepatitis delta, C, and E agents has expanded the understanding of disease clinical spectra.
Universal immunization against hepatitis B has been recommended for HBV prevention.
Interferon alfa-2a and alfa-2b show potential in treating chronic hepatitis B and C.

Conclusions:

Further research is crucial for treating and preventing other viral hepatitis types, particularly in immunocompromised individuals.
Liver transplantation is a viable option for patients with end-stage liver disease.
Continued advancements in diagnostics and therapeutics are essential for managing viral hepatitis.